19/01/2024 -
Designed to enable the rapid generation and selection of high-yielding mammalian CHO cell lines for therapeutic protein and recombinant vaccine production.
26/12/2023 -
For the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an...